IBDEI0JK ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9512,1,4,0)
 ;;=4^356.9
 ;;^UTILITY(U,$J,358.3,9512,1,5,0)
 ;;=5^Peripheral Neuropathy, Unsp
 ;;^UTILITY(U,$J,358.3,9512,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,9513,0)
 ;;=780.2^^58^632^14
 ;;^UTILITY(U,$J,358.3,9513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9513,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,9513,1,5,0)
 ;;=5^Syncope Or Presyncope
 ;;^UTILITY(U,$J,358.3,9513,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,9514,0)
 ;;=724.3^^58^632^8
 ;;^UTILITY(U,$J,358.3,9514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9514,1,4,0)
 ;;=4^724.3
 ;;^UTILITY(U,$J,358.3,9514,1,5,0)
 ;;=5^Sciatica
 ;;^UTILITY(U,$J,358.3,9514,2)
 ;;=^108484
 ;;^UTILITY(U,$J,358.3,9515,0)
 ;;=780.39^^58^632^13
 ;;^UTILITY(U,$J,358.3,9515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9515,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,9515,1,5,0)
 ;;=5^Seizures
 ;;^UTILITY(U,$J,358.3,9515,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,9516,0)
 ;;=782.0^^58^632^5
 ;;^UTILITY(U,$J,358.3,9516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9516,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,9516,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,9516,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,9517,0)
 ;;=435.9^^58^632^15
 ;;^UTILITY(U,$J,358.3,9517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9517,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,9517,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,9517,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,9518,0)
 ;;=729.1^^58^632^3
 ;;^UTILITY(U,$J,358.3,9518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9518,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,9518,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,9518,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,9519,0)
 ;;=434.91^^58^632^1
 ;;^UTILITY(U,$J,358.3,9519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9519,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,9519,1,5,0)
 ;;=5^CVA,Stroke
 ;;^UTILITY(U,$J,358.3,9519,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,9520,0)
 ;;=345.91^^58^632^9
 ;;^UTILITY(U,$J,358.3,9520,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9520,1,4,0)
 ;;=4^345.91
 ;;^UTILITY(U,$J,358.3,9520,1,5,0)
 ;;=5^Seizure Disorder NOS w/ Intr Epil
 ;;^UTILITY(U,$J,358.3,9520,2)
 ;;=^268478
 ;;^UTILITY(U,$J,358.3,9521,0)
 ;;=780.33^^58^632^7
 ;;^UTILITY(U,$J,358.3,9521,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9521,1,4,0)
 ;;=4^780.33
 ;;^UTILITY(U,$J,358.3,9521,1,5,0)
 ;;=5^Post Traumatic Seizures
 ;;^UTILITY(U,$J,358.3,9521,2)
 ;;=^339635
 ;;^UTILITY(U,$J,358.3,9522,0)
 ;;=345.80^^58^632^12
 ;;^UTILITY(U,$J,358.3,9522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9522,1,4,0)
 ;;=4^345.80
 ;;^UTILITY(U,$J,358.3,9522,1,5,0)
 ;;=5^Seizure Recurrent w/o Intr Epil
 ;;^UTILITY(U,$J,358.3,9522,2)
 ;;=^334269
 ;;^UTILITY(U,$J,358.3,9523,0)
 ;;=345.81^^58^632^11
 ;;^UTILITY(U,$J,358.3,9523,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9523,1,4,0)
 ;;=4^345.81
 ;;^UTILITY(U,$J,358.3,9523,1,5,0)
 ;;=5^Seizure Recurrent w/ Intr Epil
 ;;^UTILITY(U,$J,358.3,9523,2)
 ;;=^334235
 ;;^UTILITY(U,$J,358.3,9524,0)
 ;;=785.9^^58^633^1
 ;;^UTILITY(U,$J,358.3,9524,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9524,1,4,0)
 ;;=4^785.9
 ;;^UTILITY(U,$J,358.3,9524,1,5,0)
 ;;=5^Abdominal Bruit
 ;;^UTILITY(U,$J,358.3,9524,2)
 ;;=^273372
 ;;^UTILITY(U,$J,358.3,9525,0)
 ;;=789.30^^58^633^4
 ;;^UTILITY(U,$J,358.3,9525,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,9525,1,4,0)
 ;;=4^789.30
 ;;^UTILITY(U,$J,358.3,9525,1,5,0)
 ;;=5^Abdominal/Pelvic Mass 
 ;;^UTILITY(U,$J,358.3,9525,2)
 ;;=^917
 ;;^UTILITY(U,$J,358.3,9526,0)
 ;;=578.1^^58^633^26
 ;;^UTILITY(U,$J,358.3,9526,1,0)
 ;;=^358.31IA^5^2
